Feb 1 2012
The New York Times examines developments in circumcision technology, after "three studies have shown that circumcising adult heterosexual men is one of the most effective 'vaccines' against [HIV] -- reducing the chances of infection by 60 percent or more." The newspaper writes, "[P]ublic health experts are struggling to find ways to make the process faster, cheaper, and safer" and "donors are pinning their hopes on several devices now being tested to speed things up." The New York Times reports on several circumcision methods currently being tested, including PrePex, which received FDA approval three weeks ago and "is clearly faster, less painful and more bloodless than any of its current rivals" (McNeil, 1/30).
This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente. |